This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Whether they are digitalhealth, medical device, biotech, or pharma companies, healthtech has costly and inefficient sales processes that often stem from a lack of foundational data & insights to reach the right target markets efficiently and effectively. physicians, physician groups, hospitals, health systems, etc).
DigitalHealth Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings.
After escaping the revolution in Iran, Sean Khozin found his way to the United States, harmonizing his passion for patients and data into a career that’s led him into startups, the FDA, and most recently J&J, where he’s now Global Head of Data Strategy – all while pursuing his love of music. The phrase “it’s […].
Biotech Showcase is true to its name – great companies are highlighted.” Tina Elder, Global Managing Director, EBD Group US, said, “Biotech Showcase has once again shown itself to be the premiere destination for innovators and partners to access a powerful network of industry decision-makers, media and top investors.
For a skydiver who’s motto is “Just jump out and go”, the journey from chasing down Sandanista kidnappers to driving Disney strategy to genomics pioneer sounds sort of rational. Lisa Alderson, founder and CEO of Genome Medical, is one of those special someones who thrives on adrenaline and channels it to great effect. Lisa went […].
Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. The higher revenue multiple for HealthTech companies reflects the fact that the healthcare market is growing rapidly and there is a lot of demand for innovative digitalhealth solutions.
Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health. Learn more at koneksahealth.com.
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges.
These figures highlight its ability to grow profitably, a rarity in healthcare IT, and its dominance in the digital physician market, which it expects to expand 5-7% annually, with Doximity aiming to outpace that. Comparatively, the healthcare sector has lagged in recent years, but 2025 is showing signs of a turnaround. Subscribe Today!
DigitalHealth Solutions: Digitalhealth solutions are gaining traction in wound care, enabling remote monitoring, telemedicine consultations, and data-driven decision-making. The increasing prevalence of these conditions is driving demand for innovative solutions and improved management strategies.
Scanwell Health moves beyond home UTI testing 6.39 LetsGetChecked collects $30M more for at-home health testing 6.41 DigitalHealth Startup EverlyWell Raises $50M 6.43 ADT Biotech 7.5 Binx Health 7.13 Cue Health 7.20 Lucira Health 7.39 Mesa Biotech (Thermo Fisher) 7.42 ADT Biotech 7.5
This pilot study represents a critical step in leveraging digitalhealth technology to enhance cancer treatment outcomes,” said John Wagner, M.D., The study, led by principal investigator Nitin Ohri, M.D., Chief Medical Officer, Koneksa. “By
This moment presents a unique opportunity for B Capital to leverage our dedicated healthcare capital and active investment strategy to find and support companies advancing the healthcare sector.” Dr. Mittendorff joined B Capital in April 2021 to lead Healthcare Fund I and B Capital’s broader healthcare initiatives globally.
“In only seven years, Health+Commerce has built a highly respected organization providing strategic programs that reach clinician, investor and consumer audiences in the multibillion-dollar medtech, biotech and digitalhealth sectors. Health+Commerce has been named an Inc.
EVERSANA INTOUCH Healthware joins five full-service affiliates and four specialty affiliates serving clients across the globe with world-class strategy, next-generation branding and creative, and innovative solutions to propel the future of life science marketing.
Bilateral partnerships of this nature not only bolster our members’ businesses on the international stage, but also spotlight the robust offerings of our local ecosystem to enterprises from other growing biotech regions such as Florida,” commented Benoit Larose, CEO of BIOQuébec.
QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners. market , along with a series of executive appointments including David Dornstreich as Chief Commercial Officer and Co-Founder Arnon Horev as Chief Strategy and Operations Officer.
Players Include 1DropDiagnostics, Abbott Laboratories, Ador Diagnostics, ADT Biotech and Akonni Biosystems DUBLIN–(BUSINESS WIRE)–The “OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct to Consumer. Scanwell Health moves beyond home UTI testing 6.34 Tasso scores $6.1M
For the organization’s 2020 vision, there are three category pillars in sight: over-the-counter (OTC) drugs (the core mission for over a century), dietary supplements, and consumer medical devices (think: the CES digitalhealth aisles, and beyond). Consumer health went opposite, up 7 points, biotech up 3, insurance up 8, pharma up 6.
Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He Colin is a proven leader with a deep understanding of the digitalhealth technology industry. Colin has demonstrated strong leadership to his teams and customers alike.” “I
What’s underneath that macro “healthcare” index number of 67 is a precipitous decline in the past year for Americans’ trust in hospitals, compared with biotech, pharma, consumer healthcare, and even health insurance — all of which grew in trust between 2018 and 2019, but not so with the hospital segment of U.S.
Founded in 2015 and headquartered in New York, m+a offers full-service capabilities to a diverse group of blue-chip pharma, biotech, and digitalhealth companies across a range of therapeutic categories, including rare diseases, mental health, oncology, CNS, dermatology, and more.
–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digitalhealth solutions to better meet the needs of healthcare professionals, regulators and patients.
The LEARNS study seeks to generate evidence to extend the Koneksa solution to new digital modalities and diseases,” said John Wagner, MD, PhD, Chief Medical Officer, Koneksa. Beacon’s mobile EEG will join more than a dozen digitalhealth technologies that are already integrated into the Koneksa solution.
The company has also partnered with European hospitals and healthcare providers to develop digitalhealth solutions. Tencent Healthcare: the technology company has developed a number of healthtech products, such as a medical image analysis platform and a digitalhealth record system.
Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis. Paige.AI : A medical imaging company specialising in AI-powered diagnostics.
The flexibility of its strategy allows RA Capital to provide seed funding to startups and to lead private, IPO, and follow-on financings for its portfolio companies, allowing management teams to drive value creation from inception through commercialization. Find out more: www.sanofiventures.com.
Cerula Care is a virtual behavioral healthcare practice that partners with specialists and tailors behavioral health care for adults with serious illness. Cerula Care is using AI/ML modeling to fuel clinical and cost outcomes related to improvement in behavioral health and reduction in hospitalizations.
Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis.
Exec Summary: Scotland has emerged as a global leader in the field of digitalhealth and care, driven by a combination of factors: A strong foundation in medical innovation: Scotland boasts a rich history of medical breakthroughs, from the world's first cloned sheep (Dolly) to pioneering research in stem cell therapy.
BrainTale offers a disruptive product that combines digitalhealth with cutting-edge fundamental research, key ingredients for success,” affirms Virginie Miath, investment director at Capital Grand Est. “We are proud to include BrainTale in our portfolio of e-health start-ups. Today, the company has gathered €4.5
The top three sectors for investment were: Digitalhealth (£244 million) Therapeutics (£225 million) Medtech (£136 million) Some of the notable deals in 2022 included: Amphista Therapeutics (£38 million) Resolution Therapeutics (£34 million) ODx (£7.6 1) Pioneering healthcare: Scotland has a long history of pioneering healthcare.
My name is Rachel Francine and I am the co-founder and CEO of musical health technologies, we created a digitalhealth platform, Singfit. Carrie: Tell me a little bit about yourself and what brings you to the Connected Health Conference? And there aren’t a lot of investors who focus on digitalhealth.
Best Mobile Innovation for Health and BioTech c. DigitalHealth and Wellness Summit. There are a number of start-ups and partnerships with operators, that point to scalable, sustainable and commercially viable use cases for digitalhealth and wellbeing. Director of Product Strategy. Digital Wellness.
About Solas BioVentures Solas BioVentures invests exclusively in the life science industry, focusing on early-stage biotech, medtech and digitalhealth companies. This strategy has been validated through a number of companies in both Fund I and II and the Colucid Pharmaceuticals exit.
BPS has long been recognized worldwide as a trusted and preferred partner of contract manufacturing services for the pharmaceutical and biotech industries. BPS has been a leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharma and biotech industries for decades.
Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. With funds totaling more than €1.2
When this occurred, it didn’t cause more than a ripple of interest outside biotech. She is the author of the recently-published book, HealthConsuming: From Health Consumer to Health Citizen. . She works with exceptional leaders seeking to build value in a transforming health care world. But the U.S.
Exec Summary: The digitalhealth IPO boom of 2021 saw a surge of companies entering the public market, but the landscape has shifted since then. Why did so many DigitalHealth companies go public in 2021? There were a confluence of factors that fueled the surge of digitalhealth companies going public in 2021: 1.
Exec Summary: The digitalhealth IPO boom of 2021 saw a surge of companies entering the public market, but the landscape has shifted since then. Why did so many DigitalHealth companies go public in 2021? There were a confluence of factors that fueled the surge of digitalhealth companies going public in 2021: 1.
.” Health Populi’s Hot Points: RealClear asked people to consult their forecasting tea leaves to consider which industries and organizations would improve the quality of health care for Americans 20 years into the future. That’s an interesting conundrum to consider.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
124 
Let's personalize your content